Edition:
United States

People: Roche Holding AG (ROG.S)

ROG.S on Virt-X Level 1

276.30CHF
11:31am EDT
Change (% chg)

CHF0.05 (+0.02%)
Prev Close
CHF276.25
Open
CHF275.00
Day's High
CHF278.40
Day's Low
CHF274.85
Volume
1,072,461
Avg. Vol
1,613,671
52-wk High
CHF283.30
52-wk Low
CHF214.90

Varney, Michael 

Dr. Michael David Varney, Ph.D., has been Member of the Enlarged Corporate Executive Committee, Head Genentech Research & Early Development (gRED) at Roche Holding Ltd since 2015. He holds Bachelor of Science degree form University of California, Los Angeles (Chemistry, 1980) and a Ph.D. from California Institute of Technology (Organic Synthesis, 1985). From 1985 to 1987 he was Postdoctoral Research Fellow at the Columbia University. In 1987 he joined Agouron Pharmaceuticals Inc., where he served until 2000 and held such positions as Research Chemist, Director Medicinal Chemistry, Senior Director of Chemistry, Senior Director of Drug Discovery, Vice President and Head of Research as well as US, Corporate Vice President, Head of Research. From 2000 to 2005 he served at Pfizer Global R&D as Vice President, Drug Discovery. In 2005 he joined Genentech Inc., where he acted as Vice President of Small Molecule Drug Discovery, Senior Vice President, Research of Small Molecule Drug Discovery and Senior Vice President, Co-Head of Research and Head Small Molecule Discovery.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Severin Schwan

11,760,500

Christoph Franz

5,745,700

Fritz Gerber

--

Andre Hoffmann

439,123

Alan Hippe

5,681,190

Cristina Wilbur

3,717,860
As Of  30 Dec 2018